Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

Supplier Opportunity – Ticagrelor 60mg Tablets in 60-Count Bottles (Group I & II)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Nac Pharmaceuticals is seeking qualified suppliers to provide Ticagrelor 60mg tablets packaged in unit-of-use 60-count bottles that fully comply with Department of Veterans Affairs packaging, labeling, and NDC standards. The opportunity is structured as a subcontract under the VA’s procurement framework, with all products required to meet strict federal pharmaceutical distribution guidelines. Responses are due by August 3, 2026, at 7:30 PM Eastern Time, and the solicitation falls under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The product must be delivered to VA facilities as specified, though the exact location of performance is not detailed in the posting. Suppliers must ensure complete adherence to VA-specific requirements for unit-dose packaging, labeling accuracy, and NDC registration to be considered for award.

General Info

Nac Pharmaceuticals seeks VA-compliant Ticagrelor 60mg unit-dose bottles, due August 3, 2026, under NAICS 325412.

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of Ticagrelor 60mg tablets in unit-of-use 60-count bottles compliant with VA packaging, labeling, and NDC requirements.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
BUPIVACAINE AND EPINEP
Solicitation # SPE2DP-26-T-4389
The contract specifies the procurement of bupivacaine and epinephrine injection in 1.8 mL cartridges containing 0.500% w/v bupivacaine hydrochloride and 0.005 mg epinephrine per mL (1:200,000), supplied in lots of 50 cartridges per container, with a total quantity of two containers. The product must be stored at controlled room temperature between 15 and 30 degrees Celsius and maintain a minimum shelf life of 15 months at the time of delivery to the first government activity, despite an 18-month maximum shelf life. All packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must be commercially packaged to ensure protection from damage and safe transport via common carrier at lowest cost to the destination. The material is not considered hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951, though all DLA Technical and Quality Requirements take precedence. Mercury or mercury-containing compounds are prohibited in direct contact with the product, except for functional uses in batteries, instruments, or sensors as permitted under NAVSEA guidelines. Delivery is required FOB destination within 20 days of order placement to the USS MIGUEL KEITH (ESB-5) in San Diego, California, with no tolerance for quantity variance. The item is identified by NSN 6505-01-189-3973 and referenced under Purchase Request 7017681406, with multiple approved manufacturers listed including DENTAL HEALTH PRODUCTS INCORPORATED, CARESTREAM DENTAL LLC, PATTERSON DENTAL, HENRY SCHEIN, INC., and BENCO DENTAL SUPPLY CO. All packaging and labeling must adhere to DLA Packaging Requirements for Procurement and palletization standards, and shipment details include vessel-specific transport instructions and government-only tracking identifiers.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
CARPROFEN TABLETS
Solicitation # SPE2DP-26-T-4392
Carprofen Tablets 100mg are chewable nonsteroidal anti-inflammatory, analgesic, and antipyretic tablets specifically formulated for dogs, supplied in bottles of 60 tablets each. The product is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, including packaging standards per Medical Marking Standard No. 1 and MIL-STD-2073-1E, with no tolerance for quantity variance. It is classified as a Type I (Code Q) item with a fixed 36-month shelf life that is non-extendable and must be stored at controlled room temperature between 15–30°C (59–86°F). The item is procured under solicitation SPE2DP-26-T-4392 with a delivery requirement of 20 days FOB destination, and inspection and acceptance occur at the delivery point. Only approved manufacturers including Zoetis Inc., Covetrus North America, LLC, and Patterson Veterinary Supply, Inc. with specified part numbers are eligible, and all supplies must be properly marked in accordance with government standards. The contracting official must submit a referral through EBS to confirm product suitability before award, and the item is identified by NSN 6509014874464 under the Department of Defense’s Medical Supply Chain PHARM FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
PENTOBARBITAL SODIU
Solicitation # SPE2DP-26-T-4387
Pentobarbital Sodium Injection, Veterinary, is a Schedule II controlled substance with high abuse potential, supplied in 250ml vials containing 6 grains of sodium pentobarbital for euthanasia purposes. Each unit is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months and must be stored under vault conditions at room temperature in compliance with DEA regulations for Schedule II drugs. The product is regulated by the FDA and must be labeled and accompanied by Safety Data Sheets (SDS) aligned with OSHA’s Hazard Communication Standard and the Globally Harmonized System, effective after June 1, 2015. Labeling and documentation must conform to 29 C.F.R. 1910.1200, and suppliers are required to train employees on these requirements. All packaging must adhere to MIL-STD-2073-1E and the latest Medical Marking Standard No. 1, with government identification removed from non-accepted supplies per RQ011. The contract, issued under solicitation SPE2DP-26-T-4387, specifies a quantity of two units, each costing $2.00, for a total price of $4.00, with delivery required within five days FOB destination. Inspection and acceptance occur at the delivery point, with zero tolerance for quantity variance. The NSN is 6509-01-485-6206, and the item is procured under the DOD’s authorized unit of issue. The point of contact for the procurement is Shairy M. Cartagena of the Department of Defense’s Medical Supply Chain PHARM FSA, with performance taking place at Lackland AFB. The product is supplied by Patterson Veterinary Supply, Inc. and Covetrus North America, LLC, identified by respective part numbers, and the acquisition falls under NAICS code 325412.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
LIDOCAINE HYDROCHLORID
Solicitation # SPE2DP-26-T-4390
Lidocaine Hydrochloride and Epinephrine Injection, USP, in a 2% concentration with a 1:100,000 epinephrine ratio, is supplied in 1.7 mL cartridges packaged in units of 50 per PG, with a total shelf life of 15 months. A minimum of 13 months of remaining shelf life is required at the time of receipt by the first government activity, and the product must be stored at controlled room temperature below 25°C (77°F), protected from light and prevented from freezing. It is labeled as latex-free and intended exclusively for local dental anesthesia via nerve block or infiltration. Packaging must conform to Commercial standards as specified in DLA’s packaging requirements, with all units sealed in protective containers and shipped in exterior containers suitable for safe delivery by common carrier at the lowest cost. Labeling and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and all packaging must adhere to the DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. Hazardous material shipping requirements specified in FED-STD-313 and TQ requirement IP025 apply if applicable, and palletization must follow RP001 guidelines. The product is regulated by the FDA and requires pre-award confirmation through EBS referral. The contract specifies three line items under solicitation SPE2DP-26-T-4390, all referencing the same NSN: 6505-01-597-1328, with delivery due within five days of award and FOB destination. Quantity requirements total 12 PGs (1200 cartridges), distributed across three delivery points: USS Tulsa (LCS-16), USS Princeton (CG-59), and the Carrier Outfitting Material Support Center in Suffolk, VA. Shipment must be sent by the fastest traceable means, prohibiting parcel post, and each order must include the correct unit of issue and quantity per unit pack. The solicitation was posted July 30, 2026, with responses due by August 5, 2026, and required delivery dates range between August 3 and August 4, 2026. Vendors are identified as Darby Dental Supply, Henry Schein Inc., and Benco Dental Supply Co., with specific part and N
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
WATER FOR INJECTION, ST
Solicitation # SPE2DP-26-T-4380
Water for Injection, Sterile, USP, is supplied in 1000ml plastic bags, packaged in units of 12 bags per package, with a total procurement quantity of 2 packages. The item is regulated by the FDA and requires strict adherence to medical marking standards, specifically the latest edition of Medical Marking Standard No. 1, as defined by DLA. It must be stored at controlled room temperature and carries a non-extendable shelf life of 24 months, classified as a TYPE I (CODE M) item under DLA requirements. All packaging and labeling must comply with MIL-STD-2073-1E and the DLA Packaging Requirements for Procurement, with government identification removed from non-accepted supplies. The product is sourced from approved manufacturers including B. BRAUN MEDICAL INC and ICU MEDICAL, INC, each with designated NDC numbers. Delivery is required FOB destination within five days of contract award, with zero variance allowed in quantity. Inspection and acceptance occur at the delivery point, with the NSN 6505-01-386-9046 and procurement reference PR 7017669520. The solicitation, issued under SPE2DP-26-T-4380, was posted on July 30, 2026, with responses due by August 5, 2026, and is managed by the Department of Defense's Medical Supply Chain Pharm FSA, with primary point of contact James Foggie.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMI
Solicitation # SPE2DP-26-T-4394
ERYTHROMYCIN OPHTHALMIC OINTMENT USP is a sterile, topical ointment containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, intended for ophthalmic use only. Each unit is packaged as a single-dose tube containing 3.5 grams of ointment, with 24 tubes per package, defined as the unit of issue. The product must have a minimum of 31 months of remaining shelf life upon receipt by the first government activity, as its total shelf life is 36 months and is non-extendable. Storage requirements mandate controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly adhere to Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and must comply with DLA’s Master List of Technical and Quality Requirements. The ointment is regulated by the FDA and must be marked and shipped in accordance with commercial packaging standards, specifically ASTM D3951 if not classified as hazardous under FED-STD-313; however, DLA requirements take precedence over all other standards. Each shipment must be delivered FOB destination within five days, using the fastest traceable means, excluding parcel post, to the specified delivery point at Fort Lewis, WA. The product is identified by NSN 6505-01-189-7090, with a single purchase order quantity of one package, and the manufacturer is PADAGIS US LLC under NDC 00574-4024-39.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LAC
Solicitation # SPE2DP-26-T-4395
RINGER'S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4395 with a total order of 7 packing groups, equivalent to 84 individual units. The product is manufactured by B. Braun Medical Inc. with NDC 00264-7750-00 and is subject to FDA regulation. Packaging must comply strictly with Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and must ensure protection from damage and breakage during transit. Each unit must be sealed and packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost to the specified destination, which is FPO AP 96675. The item has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C), with brief exposure up to 40°C permitted. Packaging must adhere to DLA’s RP001 requirements and the latest DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. No hazard classification applies under FED-STD-313, so commercial packaging per ASTM D3951 is acceptable but subordinate to DLA standards. Delivery is required within 20 days of contract award, with zero quantity variance allowed, and inspection and acceptance occur at the delivery point. The unit of issue is packing group (PG), with each PG containing 12 units. All markings, labeling, and palletization must conform to specified DLA and federal standards, and shipping instructions must follow DLAD Proc Note C19 and C20. The solicitation closed on August 5, 2026, with an original required delivery date of August 3, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANS
Solicitation # SPE2DP-26-T-4384
POVIDONE-IODINE CLEANSING SOLUTION, USP, with 7.5% active ingredient, is procured for external use only in 1-gallon bottles, designated by the unit of issue BT, with a total shelf life of 36 months; at least 31 months of shelf life must remain upon delivery to the first government activity. Storage must be maintained at 25°C (77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). The product is regulated by the FDA and must comply with all applicable DLA Master List of Technical and Quality Requirements, including packaging standards RP001 and labeling mandates under the Hazard Communication Standard, requiring Safety Data Sheets and GHS-compliant labels submitted for approval prior to award. All packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and be commercially sealed to prevent damage, with palletization following DLA guidelines. The item is classified as hazardous per Fed-Std-313 and must be packaged according to TQ requirement IP025. Five 1-gallon units are required under two contract line items, both with identical NSN 6505009947224, each priced individually, with zero variance allowed in quantity. Delivery is FOB destination within 20 days, inspected and accepted at the destination point. Shipments must be traceable and dispatched via freight, not parcel post, with delivery address to USS HARPERS FERRY LSD 49, FPO AP 96665. The original required delivery date is August 3, 2026, and the product must be labeled with the specified manufacturer part numbers from Cardinal Health 200, LLC and Purdue Pharma LP. All documentation, including SDS and labels, must align with 29 C.F.R. 1910.1200, and supplier employees must be trained on updated hazard communication requirements. The contract is issued under solicitation SPE2DP-26-T-4384 with the NAICS code 325412 and is managed by the Department of Defense's Medical Supply Chain PHAR FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
WATER FOR IRRIGATION, S
Solicitation # SPE2DP-26-T-4383
This contract specifies the procurement of sterile irrigation water, USP, in 1000 mL semi-rigid plastic containers with screw caps, optionally featuring a hanging device, intended exclusively for sterile irrigation, washing, rinsing, and dilution purposes and not for parenteral injection. The product must be distilled, nonpyrogenic, and packaged in units of issue consisting of 12 containers per package, with a non-extendable shelf life of 36 months. It is regulated by the FDA and must comply with the latest edition of Medical Marking Standard No. 1 and MIL-STD-129 for labeling and packaging, adhering to DLA’s Master List of Technical and Quality Requirements. Storage must be maintained at controlled room temperature between 20°C and 25°C, and protection from freezing and excessive heat is mandatory. The item is supplied by Baxter Healthcare Corporation under part number 2F7114 and NDC 00338-0004-04, with a unit price and total price to be determined upon award. Delivery is required FOB destination within 20 days of contract award, with zero variance allowed in quantity acceptance, and inspection and acceptance occur at the delivery point. The shipment is destined for USS ILLINOIS SSN-786 at FPO AP 96694, and compliance with DLA packaging and transportation protocols, including Fed-Std-313 and ASTM D3951 for non-hazardous materials, is required. All packaging must be palletized in accordance with RP001 and marked in full compliance with DLA standards. The solicitation, identified as SPE2DP-26-T-4383, was posted on July 30, 2026, with responses due by August 5, 2026, and the original required delivery date is August 3, 2026. The contracting official must submit a referral through EBS to confirm regulatory status, including bidder and manufacturer details, prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE TOP
Solicitation # SPE2DP-26-T-4386
Povidone-Iodine Topical Solution, USP, in a 10 percent concentration, 1/2 fl oz (15 mL) bottle, is being procured in units of 50 bottles per parcel grouped under the unit of issue “PG.” The contract requires a total of two PG units, with one unit having a required delivery date of August 3, 2026, and the other by August 4, 2026, both subject to a 20-day delivery window. At the time of delivery to the first government activity, each shipment must retain at least 31 months of the full 36-month shelf life, which is non-extendable. Packaging and labeling must strictly adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and all units must be commercially packaged in sealed containers that protect against damage, with palletization conforming to DLA’s packaging requirements. The product is regulated by the FDA and classified as a critical application item, requiring compliance with all applicable DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951 or other commercial standards. Hazardous material handling guidelines under FED-STD-313 and IP025 apply if applicable, but the item is generally expected to be commercially packaged. Shipments must be sent via traceable means, explicitly prohibiting parcel post, and delivered to designated military freight addresses in San Antonio, Texas. The manufacturer is Purdue Pharma LP with NDC 67618-0150-05, and the NSN is 6505-00-914-3593. The contracting official must submit a referral via EBS for product confirmation, including manufacturer and bidder details. Total quantity ordered is 100 bottles, with a unit price of $1.00 per PG, resulting in a total contract value of $2.00. All packaging must be marked in accordance with established government standards, and no quantity variance is permitted.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DEXTROSE INJECTION
Solicitation # SPE2DP-26-T-4393
Dextrose Injection 5% USP, 1000 mL, is a sterile, nonpyrogenic intravenous solution supplied in single-dose plastic bags, each containing 5 grams of anhydrous dextrose USP in water for injection USP, and is labeled as latex-free. The product is intended solely for intravenous administration and is packaged in units of 12 bags per package, with a strict shelf-life requirement of 30 months that is non-extendable. Storage must be maintained between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat, in compliance with USP controlled room temperature standards. The item is subject to the latest DLA Master List of Technical and Quality Requirements, and packaging must adhere to MIL-STD-129 and the Medical Marking Standard No. 1, with no deviation permitted from DLA specifications even if ASTM D3951 is otherwise applicable. The product is not classified as hazardous under FED-STD-313, so commercial packaging standards are secondary to DLA requirements. Two separate delivery lines are specified under contract SPE2DP-26-T-4393, each for one package of 12 units, to be delivered FOB destination within five days of shipment, with no tolerance for quantity variance. Deliveries are directed to two U.S. Navy vessels, USS Jefferson City and USS Delaware, with shipping instructions requiring traceable transport and explicitly prohibiting parcel post. The contract specifies a required delivery date of August 3, 2026, and includes government-specific identifiers, logistics codes, and procurement data tied to the NSN 6505-01-330-6252, with full technical and quality compliance governed by DLA directives that supersede all other standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DOXYCYCLINE HYCLATE
Solicitation # SPE2DP-26-T-4150
The contract specifies the procurement of Doxycycline Hyclate Tablets, USP equivalent to 100 mg of doxycycline, packaged in bottles of 100 tablets each, with a total quantity of eight bottles to be delivered within 20 days after award. The item is regulated by the FDA and has a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. Packaging must comply with commercial standards as defined in the procurement document, with each unit sealed in a protective container and shipped in commercial exterior containers suitable for safe transport at the lowest cost. Medical items are subject to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for all marking and labeling requirements, including barcoding and traceability, and must be followed strictly. Palletization and shipping must adhere to RP001 DLA packaging requirements, and if the product is classified as hazardous under FED-STD-313, it must be packaged per IP025; otherwise, ASTM D3951 applies but is subordinate to all DLA technical and quality requirements. The delivery is FOB destination to Fort Bragg, North Carolina, and shipments must be sent via traceable means, explicitly prohibiting the use of parcel post. The contract mandates electronic submission of payment requests through WAWF and requires compliance with numerous FAR and DFARS clauses covering equal opportunity, trafficking prohibitions, cybersecurity, hazardous materials, export controls, and small business representations. Offerors must hold valid UEI and CAGE codes and disclose any socioeconomic status, including eligibility under small business programs. All packaging and labeling must be consistent with Medical Marking Standard No. 1A dated February 4, 2013, and suppliers must ensure product integrity by storing at controlled room temperature between 20 to 25°C and protecting from light and moisture. The item’s NDC is 62135-0626-01, and the NSN is 6505-01-600-3042, with no tolerance allowed for quantity variance. The requirement to confirm bidder and manufacturer details through EBS referral to the product specialist must be fulfilled by the contracting officer prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
Supplier Opportunity – Ticagrelor 90mg Tablets in Bulk Bottles (500 or 1,000 Count) – Group I OnlyNac Pharmaceuticals is seeking qualified suppliers to provide Ticagrelor 90mg tablets in bulk packaging of either 500 or 1,000 tablets per bottle for use by the Department of Veterans Affairs and the Department of Defense institutional pharmacies under Group I. The contract is classified as a subcontract and is specifically designated for this therapeutic formulation and packaging configuration, with no set-aside provisions applicable. The NAICS code 325412 indicates the manufacturing of pharmaceutical preparations, aligning with the production and supply requirements. Interested parties must submit responses by August 3, 2026, at 7:30 PM ET, following the solicitation window that opened on July 30, 2026. Product must meet all applicable quality, labeling, and regulatory standards for institutional pharmacy distribution within federal healthcare systems.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
Federal
Supplier Opportunity – Ticagrelor 60mg Tablets in Bulk Bottles (500 or 1,000 Count) – Group I OnlyNac Pharmaceuticals, acting on behalf of the Department of Veterans Affairs, is seeking suppliers to provide Ticagrelor 60mg tablets in bulk packaging options of 500 or 1,000 tablets per bottle for institutional dispensing under Group I. The opportunity is structured as a subcontract and is open for responses until August 3, 2026, at 7:30 PM Eastern Time. The product must comply with pharmaceutical standards for institutional use and be packaged in accordance with institutional supply requirements. The NAICS code 325412 identifies this as a pharmaceutical and botanical product manufacturing activity. All submissions must meet the specified packaging and quantity requirements, and performance will be limited to institutional settings under Group I procurement protocols. There is no set-aside designation, and the award will be made based on submitted proposals satisfying contractual obligations.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
Federal
Supplier Opportunity – Ticagrelor 90mg Tablets in 60-Count Bottles (Group I & II)Nac Pharmaceuticals is seeking qualified suppliers to provide Ticagrelor 90mg tablets in 60-count bottles that comply with Department of Veterans Affairs packaging, labeling, and regulatory requirements. This subcontract opportunity is open for bids with a tight deadline of August 3, 2026, at 7:30 PM Eastern Time, and falls under NAICS code 325412 for pharmaceutical and biological product manufacturing. The product must meet all VA-specific standards for identity, potency, stability, and documentation to ensure seamless integration into the VA healthcare supply chain. Suppliers must be prepared to demonstrate capacity for consistent, large-scale production and adherence to federal pharmaceutical regulations, with no set-aside preferences indicated for small or disadvantaged businesses. All bids must be submitted through the SAM.gov platform prior to the deadline.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 3 days
View Details
NAICS: 325412
New
Federal
6505--Ticagrelor Tablets
Solicitation # 36E79726R0028
The Department of Veterans Affairs through its National Acquisition Center is preparing to issue an unrestricted solicitation for Ticagrelor Tablets under solicitation number 36E79726R0028, targeting supply to VA facilities including Consolidated Mail Order Pharmacies and State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The procurement is divided into two mutually exclusive groups: Group I includes both 60-count bottles and bulk packaging options of 500 or 1,000 tablets per bottle for both 60mg and 90mg strengths, while Group II includes only 60-count bottles for the same strengths. Offerors must submit complete proposals for one group only, and award will go to the lowest-priced technically acceptable bid based on total evaluated price. The contract has a base term of one year with four optional one-year extensions, and product distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. All offered products must bear the offeror’s unique NDC number and be labeled exclusively with that label, with no over-labelling permitted. VA labels must be capable of adhering securely on top of the contractor’s label. Packaging requirements are strict: unit-of-use bottles must have safety caps with deshellable or convertible features, meet minimum size specifications including 120cc capacity and 5.75-inch circumference, fit a label measuring 5.25 x 2 inches with an additional 0.5 inch for barcodes and expiration details, and feature a cylindrical body. Total annual estimated demand is approximately 21,137 bottles of 60mg 60-count, 141,992 bottles of 90mg 60-count for Group I combined with either 500 or 1,000 tablet bulk options, and for Group II, approximately 52,237 and 205,992 bottles of 60mg and 90mg 60-count respectively. The solicitation will be released electronically on or about August 18, 2026, with a proposed closing date of September 1, 2026, under NAICS code 325412. All information is accessible only through SAM.gov, and inquiries must be directed via email to Kenneth Lay. No paper copies will be provided.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 3 days
View Details
NAICS: 541611
New
Federal
Small Business Subcontracting Plan Development & ReportingThe contract requires the development, implementation, and ongoing reporting of a small business subcontracting plan that fully complies with Veterans Affairs guidelines, using the electronic Subcontracting Reporting System eSRS. The work must be performed in alignment with the NAICS code 541611, which pertains to management consulting services, and the plan must be designed to meet federal obligations for small business participation under VA procurement regulations. The contractor will be responsible for ensuring accurate data submission, proper classification of subcontractor types, and adherence to all VA-specific reporting standards throughout the duration of the project. The solicitation is issued under the Department of Veterans Affairs through Nac Pharmaceuticals and has a response deadline of August 13, 2026, with the opportunity posted on July 28, 2026. There is no specified set-aside type, and the place of performance and point of contact details are not provided. The contractor must be prepared to operate within the VA’s compliance framework, maintain transparent records of small business subcontracting efforts, and generate regular, auditable reports through eSRS to demonstrate progress and adherence to federal goals for small business inclusion. The successful bidder will need expertise in federal subcontracting compliance, experience with VA systems and reporting protocols, and a thorough understanding of eSRS workflows and deadlines.
Administrative Management and General Management Consulting Services

POSTED

4 days ago

DEADLINE

in 13 days
View Details
NAICS: 484220
New
Federal
Logistics and Distribution to PPV CentersThe contract pertains to the logistics and distribution of finished pharmaceuticals under FOB Destination terms to Department of Veterans Affairs and Department of Defense Prime Vendor distribution centers across the United States, ensuring timely and compliant delivery to federal healthcare supply nodes. It is structured as a subcontract with a NAICS code of 484220, indicating a focus on specialized freight logistics, and is issued by Nac Pharmaceuticals under the authority of the Department of Veterans Affairs. The solicitation is open for responses until August 13, 2026, with a firm deadline of 7:30 PM Eastern Time, requiring proposers to meet strict operational, regulatory, and supply chain standards to qualify for award, particularly around cold chain management, inventory accuracy, and federal delivery protocols. Delivery must align with federal procurement requirements, including traceability, security, and compliance with federal药品 regulations, and performance is expected nationwide without geographic restriction within the U.S.
Specialized Freight (except Used Goods) Trucking, Local

POSTED

4 days ago

DEADLINE

in 13 days
View Details
NAICS: 541330
New
Federal
Serialization and DSCSA Compliance ServicesNac Pharmaceuticals is seeking a subcontractor to provide comprehensive serialization and DSCSA compliance services, including full end-to-end implementation of GS1 Data Matrix encoding for product units, handling of EPCIS transaction data to ensure traceability across the pharmaceutical supply chain, and integration with the NABP directory for accurate verification and validation of product information. The work requires strict adherence to federal serialization regulations to support secure, interoperable tracking of pharmaceuticals from manufacturer to dispenser, with all data properly formatted and transmitted in compliance with DSCSA milestones. Subcontractors must demonstrate technical capability in GS1 standards, EPCIS messaging protocols, and NABP system integration to meet the operational demands of a major federal healthcare provider. The opportunity is posted under NAICS code 541330 and has a response deadline of August 13, 2026, with no set-aside classification specified. While the place of performance and point of contact are not detailed, the contract is tied to the Department of Veterans Affairs through Nac Pharmaceuticals as the prime contractor.
Engineering Services

POSTED

4 days ago

DEADLINE

in 13 days
View Details
NAICS: 326199
New
Federal
Pharmaceutical Packaging Materials SupplyNac Pharmaceuticals is seeking a subcontractor to supply high-density polyethylene (HDPE) bottles, child-resistant caps, and compliant labels for unit-of-use pharmaceutical packaging. The materials must meet stringent pharmaceutical standards to ensure safety, compliance, and functionality in a unit-dose format, with particular emphasis on child-resistant features and regulatory labeling requirements. The procurement is classified under NAICS code 326199, indicating it pertains to other plastic product manufacturing, and the anticipated contract award is intended to support the Department of Veterans Affairs' pharmaceutical distribution needs. Interested parties must submit responses by August 13, 2026, at 7:30 PM Eastern Time, with the solicitation posted on July 28, 2026. The performance location and detailed delivery specifications are not explicitly defined in the posting, but successful bidders will be expected to adhere to all applicable federal pharmaceutical packaging regulations and deliver materials that meet exact quality and certification benchmarks without deviation.
All Other Plastics Product Manufacturing

POSTED

4 days ago

DEADLINE

in 13 days
View Details
NAICS: 325412
New
Federal
Tablet Manufacturing and PackagingNac Pharmaceuticals, acting on behalf of the Department of Veterans Affairs, is seeking a subcontractor to manufacture and package pioglitazone 15mg tablets in 30- and 90-tablet unit-of-use bottles under current Good Manufacturing Practices and the Drug Supply Chain Security Act requirements. The work must adhere to strict regulatory standards to ensure product safety, traceability, and compliance with federal pharmaceutical guidelines. The solicitation was posted on July 28, 2026, and responses are due by August 13, 2026, at 7:30 PM Eastern Time. The NAICS code 325412 identifies this as a pharmaceutical and medicinal product manufacturing opportunity. All manufacturing and packaging activities are expected to occur at the contractor’s facility, with no specified place of performance indicated. The contract is structured as a subcontract and is not subject to any set-aside provisions.
Pharmaceutical Preparation Manufacturing

POSTED

4 days ago

DEADLINE

in 13 days
View Details
NAICS: 325411
New
Federal
Active Pharmaceutical Ingredient (API) SupplyNac Pharmaceuticals is seeking a subcontractor to supply Pioglitazone Active Pharmaceutical Ingredient (API) that meets USP-NF standards and complies with the Trade Agreements Act for use in the manufacturing of finished dosage forms. The opportunity is posted under NAICS code 325411, indicating classification within pharmaceutical preparation manufacturing, and the response deadline is August 13, 2026, at 7:30 PM Eastern Time. The API must adhere strictly to pharmacopeial specifications to ensure quality, safety, and compatibility with regulatory requirements for final product approval. The place of performance and point of contact details are not specified, suggesting the supplier’s location and logistics are flexible as long as deliverables meet contractual obligations. This procurement is part of a broader initiative by the Department of Veterans Affairs through its contractor Nac Pharmaceuticals, to secure a reliable supply chain for critical drug components in support of federal healthcare programs.
Medicinal and Botanical Manufacturing

POSTED

4 days ago

DEADLINE

in 13 days
View Details
NAICS: 325412
New
Federal
6505--Pioglitazone Tablets
Solicitation # 36E79726R0030
The contract titled 6505--Pioglitazone Tablets is a solicitation issued by the Department of Veterans Affairs through Nac Pharmaceuticals with the solicitation number 36E79726R0030, posted on July 28, 2026, and with a response deadline of August 13, 2026, at 7:30 PM ET. The North American Industry Classification System code 325412 identifies this as a pharmaceutical manufacturing contract, specifying the procurement of pioglitazone tablets, a medication used primarily for diabetes management. The office responsible for this solicitation is located in Hines, Illinois, with a ZIP code of 60141, and the place of performance details are not specified. The primary point of contact is Teresa Hussain, Senior Contract Specialist, reachable via email at teresa.hussain@va.gov. There is no set-aside designation indicated for this opportunity, meaning it is open to all eligible vendors without restriction based on small business, veteran-owned, or other classifications. Interested parties must submit proposals through the SAM.gov portal before the deadline to be considered for award.
Pharmaceutical Preparation Manufacturing

POSTED

4 days ago

DEADLINE

in 13 days
View Details
NAICS: 493110
Federal
Pharmaceutical Logistics and Distribution to Prime Vendors
General Warehousing and Storage

POSTED

6 months ago

DEADLINE

N/A
View Details